Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its executive team are scheduled to participate in the upcoming investor conference, detailed below:
- Life Sciences Van Lanschot Kempen Conference
Event dates: April 1 – 3, 2025 | Amsterdam, Netherlands
| Press release in English | 120.24 KB |
| Communiqué de presse en français | 97.62 KB |